Related Experiment Video
Updated: Jan 4, 2026

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
Physician Perceptions of Step Therapy Prescribing Requirements
Michael A Fischer1, Aaron S Kesselheim1, Zhigang Lu1
1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts.
Physicians see potential in step therapy for improving drug affordability and appropriateness. However, concerns about inefficient implementation and industry interactions may negatively impact physician acceptance of these cost-management policies.
Area of Science:
- Health policy research
- Pharmaceutical economics
- Physician behavior studies
Background:
- Step therapy policies are widely used by insurers to control medication costs.
- Physician perceptions of step therapy have not been extensively studied.
- Understanding physician attitudes is crucial for effective policy implementation.
Purpose of the Study:
- To assess physician attitudes towards step therapy policies.
- To examine the relationship between physician characteristics and their views on step therapy.
- To identify factors influencing physician acceptance of cost-containment strategies.
Main Methods:
- A survey was distributed to internal medicine, cardiology, and endocrinology physicians.
- The survey utilized a 5-point Likert scale to gauge opinions on clinical, economic, and implementation aspects.
- Data collected included physician demographics and pharmaceutical industry interaction levels.
Main Results:
- 70% of respondents reported interactions with the pharmaceutical industry.
- Physicians agreed step therapy could improve affordability (55%) and clinical appropriateness (59%).
- However, physicians perceived step therapy as inefficient, inflexible, and lacking patient-specific considerations, with subspecialists and those interacting with industry holding more negative views.
Conclusions:
- Physicians acknowledge step therapy's potential for cost and quality improvement.
- Industry interactions may influence physician opinions on step therapy.
- Perceived implementation issues significantly reduce physician acceptance of step therapy policies.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Dosage Regimen: Individualization
Drug Abuse and Addiction: Pharmacological Phenomena
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Dosage Regimens: Designs and Approaches

